IMNN
Imunon, Inc.
Imunon, Inc. (IMNN) has 22 SEC Form 4 filings (25 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 21, 2026.
The most active filer is General Counsel and Corp Sec Eylward Susan with 3 filings.
- Industry:Biotechnology
- CEO:Stacy R. Lindborg
- Employees:25
- HQ:Lawrenceville, NJ, US
- IPO:1999-03-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$26K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$7.4M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| General Counsel and Corp Sec | Sale | 2,150 | $4K | Jul 21 | SEC ↗ | |
| General Counsel and Corp Sec | Sale | 920 | $2K | Jul 7 | SEC ↗ | |
Eylward SusanFirst filing | General Counsel and Corp Sec | Sale | 11,800 | $21K | Jun 29 | SEC ↗ |
Related companies
Imunon, Inc. is in the Healthcare sector.